Last updated 2026-06-18
- Acquired by insitro, Jan 2026
- Raised funding round led by AION Labs, Mar 2024
Total raised
—
Last: 2024-03
Stage
Acquired
Founded
2023
Headcount
2
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
CombinAble offers a revolutionary approach to therapeutic design. Its unique AI platform moves beyond standard antibodies, enabling the rapid in silico development of complex formats, including bi-specifics, tri-specifics, and T-cell engagers.
The platform enables development of best-in-class therapeutics in just 4 months—dramatically faster than traditional methods. This accelerated timeline, even for the most complex biologics, gives our partners a significant competitive advantage.
Funding history · 1 round · — total
2024-03
Undisclosed
Q&A
- What is CombinAble.AI's primary focus?
- CombinAble.AI specializes in tailored antibody optimization, using an AI platform for the in silico development of complex therapeutic formats like bi-specifics, tri-specifics, and T-cell engagers.
- When was CombinAble.AI founded?
- CombinAble.AI was founded in August 2023.
- What is the current employee count for CombinAble.AI?
- CombinAble.AI has 1-10 employees.
- What is CombinAble.AI's current status?
- CombinAble.AI is currently active and was acquired by insitro in January 2026.
- Which investor participated in CombinAble.AI's funding round in March 2024?
- AION Labs participated in CombinAble.AI's funding round in March 2024.
- In which country is CombinAble.AI headquartered?
- CombinAble.AI is headquartered in Rehovot, Israel.
- What sectors does CombinAble.AI operate in?
- CombinAble.AI operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, and Drugs Discovery & Development.
- What technology does CombinAble.AI utilize?
- CombinAble.AI utilizes Artificial Intelligence in its platform.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B
Tags
drug-developmentartificial-intelligencebiopharmaceuticalbiotechnologytherapeuticspharmaceuticalsantibodies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | combinableai.com/ |
|---|---|
| linkedin.com/company/100601708/ |
Identifiers & details
| Founded | 2023-8 |
|---|---|
| Employees (exact) | 2 |
| Status reason | Acquired by insitro on Jan 2026 |
Acquisitions & public offerings
Acquired by insitro 2026-01
Radar intelligence
Web history (Wayback)
| Domain | combinableai.com |
|---|